During the past decade, Shores Rheumatology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 11 clinical trials were completed, i.e. on average, 183.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shores Rheumatology" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shores Rheumatology" #1 collaborator was "Biogen" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Shores Rheumatology" are "Rheumatoid Arthritis" (5 trials), "Arthritis, Rheumatoid" (3 trials), "Arthritis" (1 trials), "Behçet's Syndrome" (1 trials) and "Giant Cell Arteritis" (1 trials). Many other conditions were trialed in "Shores Rheumatology" in a lesser frequency.

Most popular intervention types in "Shores Rheumatology" are "Drug" (12 trials), "Biological" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Methotrexate" (3 trials), "Allopurinol" (1 trials), "Anti-TNF-alpha" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shores Rheumatology" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Shores Rheumatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Shores Rheumatology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Shores Rheumatology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".